Prelude Capital Management, LLC Merck & Co., Inc. Transaction History

Prelude Capital Management, LLC

$1.85 Billion
Q1 2024

A detailed history of Prelude Capital Management, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Prelude Capital Management, LLC holds 3,442 shares of MRK stock, worth $426,119. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,442

Previous 14,550 76.34%

Holding current value

$426,119

Previous $1.59 Million 71.37%

% of portfolio

0.02%

Previous 0.11%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$113.24 - $131.95 $1.26 Million - $1.47 Million	-11,108 Reduced 76.34%	3,442 $454,000
Q4 2023 Feb 14, 2024	BUY	$100.18 - $109.02 $1.46 Million - $1.59 Million	14,550 New	14,550 $1.59 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $804,894 - $904,209	9,522 New	9,522 $820,000
Q2 2022 Aug 15, 2022	SELL	$83.49 - $94.64 $248,800 - $282,027	-2,980 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $1.22 Million - $1.37 Million	-16,647 Reduced 84.82%	2,980 $245,000

Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $1.05 Million - $1.31 Million	14,464 Added 280.15%	19,627 $1.5 Million
Q3 2021 Nov 15, 2021	BUY	$71.68 - $78.83 $370,083 - $406,999	5,163 New	5,163 $388,000
Q2 2021 Aug 16, 2021	SELL	$70.31 - $77.77 $2.41 Million - $2.67 Million	-34,336 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$68.86 - $81.11 $1.88 Million - $2.21 Million	27,278 Added 386.48%	34,336 $2.66 Million
Q4 2020 Feb 16, 2021	BUY	$71.77 - $79.65 $322,606 - $358,026	4,495 Added 175.38%	7,058 $577,000
Q3 2020 Nov 16, 2020	SELL	$73.18 - $82.95 $2 Million - $2.27 Million	-27,393 Reduced 91.44%	2,563 $213,000
Q2 2020 Aug 14, 2020	BUY	$70.42 - $80.13 $2.1 Million - $2.39 Million	29,797 Added 18740.25%	29,956 $2.32 Million
Q1 2020 May 15, 2020	SELL	$63.36 - $87.82 $389,347 - $539,653	-6,145 Reduced 97.48%	159 $12,000
Q4 2019 Feb 14, 2020	SELL	$77.58 - $87.54 $152,522 - $172,103	-1,966 Reduced 23.77%	6,304 $573,000
Q3 2019 Nov 14, 2019	SELL	$76.08 - $82.93 $1.37 Million - $1.49 Million	-17,988 Reduced 68.5%	8,270 $696,000
Q2 2019 Aug 14, 2019	BUY	$69.84 - $81.59 $950,941 - $1.11 Million	13,616 Added 107.7%	26,258 $2.2 Million
Q1 2019 May 15, 2019	SELL	$69.58 - $79.36 $472,100 - $538,457	-6,785 Reduced 34.93%	12,642 $1.05 Million
Q4 2018 Feb 14, 2019	BUY	$65.24 - $75.71 $60,086 - $69,728	921 Added 4.98%	19,427 $1.48 Million
Q3 2018 Nov 14, 2018	BUY	$57.69 - $67.84 $86,650 - $101,895	1,502 Added 8.83%	18,506 $1.31 Million
Q2 2018 Aug 14, 2018	BUY	$50.83 - $59.72 $270,008 - $317,232	5,312 Added 45.43%	17,004 $1.03 Million
Q1 2018 May 15, 2018	BUY	$50.96 - $59.23 $595,824 - $692,517	11,692 New	11,692 $637,000
Q4 2017 Feb 14, 2018	SELL	$51.62 - $61.64 $1.43 Million - $1.71 Million	-27,732 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $1.63 Million - $1.75 Million	27,732	27,732 $1.78 Million

Others Institutions Holding MRK

# of Institutions

3,766

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $314B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Account

Prelude Capital Management, LLC Merck & Co., Inc. Transaction History